Share via Email

* Email To: (Separate multiple addresses with a semicolon)
* Your Name:
* Email From: (Your IP Address is
* Email Subject: (personalize your subject)

Email Content: Poultry Industry News, Comments and more by Simon M. Shane

Boehringer Ingelheim Completes Athens GA. Vaccine Plant


A $76 million investment by Boehringer Ingelheim has doubled capacity to produce animal vaccines in a plant located in Athens, GA.  Everett Hoekstra, president of Boehringer Ingelheim Animal Health USA, Inc. stated, “Today’s announcement is representative of the growth and investment Boehringer Ingelheim is making around the United States. It also signals our commitment to a world in which no animal suffers from a preventable disease.”


Senator David Perdue (R-GA) who attended the opening ceremony noted, “Boehringer Ingelheim continues to be a strong contributor to our economy, their investment in Georgia is a testament to our outstanding universities, growing biosciences industry, and business-friendly climate.”

Since acquisition of the U.S. Animal Health business of Sanofi of France, Boehringer Ingelheim  has invested $124 million in the state of Georgia creating 225 jobs in Athens, Duluth and Gainesville.  The plant located in Athens produces a range of 150 vaccines for pets, poultry and wildlife sold in more than 80 nations.

Copyright © 2020 Simon M. Shane